Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease

@inproceedings{Ghouri2014SystematicRO,
  title={Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease},
  author={Yezaz Ahmed Ghouri and David M. Richards and Erik F. Rahimi and Joseph T Krill and Katherine A. Jelinek and Andrew W. Dupont},
  booktitle={Clinical and experimental gastroenterology},
  year={2014}
}
BACKGROUND Probiotics are microorganisms that are ingested either in combination or as a single organism in an effort to normalize intestinal microbiota and potentially improve intestinal barrier function. Recent evidence has suggested that inflammatory bowel disease (IBD) may result from an inappropriate immunologic response to intestinal bacteria and a disruption in the balance of the gastrointestinal microbiota in genetically susceptible individuals. Prebiotics, synbiotics, and probiotics… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS
53 Citations
84 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 53 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 84 references

FLORABEST Study Group. Saccharomyces boulardii does not prevent relapse of Crohn’s disease

  • A Bourreille, G Cadiot, G Le Dreau
  • Clin Gastroenterol Hepatol
  • 2013
Highly Influential
4 Excerpts

Similar Papers

Loading similar papers…